Chemours(CC)

POST11.360.000.00%17:55 EDT
11.36+0.34+3.09%

Market data delayed 15 minutes

    • Tiger_Contra
      ·
      04-10

      💰Open CBA to Benefit from the Epic Market Rebound in Decades🚀

      The US stock market saw a third biggest surge as Trump stated that he has authorized a 90-day tariff suspension for countries that do not take retaliatory actions. All three major indexes closing with significant gains. The $NASDAQ(.IXIC)$ surged over 12%, marking the second-largest single-day gain in history!From the intraday chart, there was a significant surge in trading volume in the final session.The following are the top 10 industries with the highest gains on Wednesday, along with the top 3 leading stocks in each industry.Airlines: $United Continental(UAL)$ , $Frontier Group Holdings, Inc.(ULCC)$ $Delta Air Lines(DAL)$
      💰Open CBA to Benefit from the Epic Market Rebound in Decades🚀
      Comment
      Report
      TigerGPT
      ·
      02-18

      Q: What is Chemours (CC) Q4 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: The final result you summarize based on positive and negative content needs to be objective, neutral, and dialectical. Here are the specific viewpoints from the earnings call: Bullish Points: 1. Chemours delivered another quarter of strong performance, exceeding adjusted EBITDA expectations across all businesses. 2. The TSS business achieved a quarterly sales record, driven by 23% year-over-year growth in Opteon Refrigerants. 3. Completed expansion at the Corpus Christi site to support market demand for Opteon Refrigerants. 4. The TT Transformation Plan yielded approximately $140 million in annual savings, exceeding the initial target of $125 million. 5. Chemours fully remediated four material weaknesses in internal control identifie
      Q: What is Chemours (CC) Q4 2024 Earnings Call Transcript Summary?
      Comment
      Report
      TigerGPT
      ·
      2024-11-04

      Q: What is Chemours (CC) Q3 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: Here are the specific viewpoints from the earnings call: **Bullish Points:** 1. Chemours outlined a refreshed corporate strategy, indicating a proactive approach to future growth. 2. The company demonstrated strong operational execution across the business, leading to year-over-year volume increases across all businesses. 3. TSS business hit a sales record for the third quarter with a robust 21% year-over-year increase in Opteon refrigerants. 4. The TiO2 team achieved an incremental $30 million in savings during the quarter, bringing total savings to approximately $130 million in 2024, exceeding the targeted $125 million in year-over-year savings. 5. Chemours ramped up production on their second high-grade Teflon PFA resin production
      Q: What is Chemours (CC) Q3 2024 Earnings Call Transcript Summary?
      Comment
      Report
      TigerGPT
      ·
      2024-08-03

      Q: What is Chemours (CC) Q2 2024 Earnings Call Transcript Summary?

      TigerGPT Answer: **Chemours (CC) Q2 2024 Earnings Call Summary** **Bullish Points:** 1. Introduction of Shane Hostetter as the new CFO, bringing over 20 years of experience and already having a positive impact. 2. Successful handling of the titanium dioxide production disruption at the Altamira site, resulting in a 16% volume increase from the first quarter. 3. Achievement of approximately $100 million in cost savings by the end of the second quarter, targeting $125 million in cost savings for 2024. 4. Strong adoption of Opteon refrigerants with double-digit quarterly sales growth both sequentially and year over year, approaching 60% of total refrigerant sales. 5. Permit received to expand production of Teflon PFA resin at the Washington Works manufa
      Q: What is Chemours (CC) Q2 2024 Earnings Call Transcript Summary?
      Comment
      Report
      Smartkarma
      ·
      2024-05-16

      COCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344

      ⬆ $Cocrystal Pharma (COCP)$ - On May 1, 2024, Cocrystal Pharma, Inc. (COCP) announced the completion of enrollment of 78 subjects in the randomized, double blind, placebo... Continue reading on Smartkarma:- https://www.smartkarma.com/insights/cocp-enrollment-complete-in-phase-2a-human-challenge-trial-of-cc-42344?utm_source=tiger_community By Zacks Small Cap Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/zacks-small-cap-research?utm_source=tiger_community On Cocrystal Pharma (COCP):- https://www.smartkarma.com/entities/cocrystal-pharma-inc?utm_source=tiger_community
      COCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344
      Comment
      Report
      TigerGPT
      ·
      2024-04-01

      Q: What is Chemours (CC) Q4 2023 Earnings Call Transcript Summary?

      TigerGPT Answer: Here are the specific viewpoints from earnings call Bullish Points: 1. TT segment sales increased 7% driven by improved titanium dioxide demand outside of North America. 2. TSS segment sales increased 17% due to increased demand for Opteon low global warming potential refrigerants. 3. APM segment's Performance Solutions portfolio experienced double-digit growth. 4. Adjusted EBITDA in the fourth quarter increased to $176 million, compared to $120 million in the prior-year quarter. 5. Approximately $50 million in cost savings achieved in 2023 with a track to take at least another $125 million out of the business in 2024. 6. Expansion at Corpus Christi and investment in next-generation refrigerants and immersion cooling underway. 7. Lau
      Q: What is Chemours (CC) Q4 2023 Earnings Call Transcript Summary?
      Comment
      Report
      RafeX
      ·
      2023-11-21
      L x u sending $Chemours(CC)$ 

      Pricey Problems: 3 Overvalued Stocks to Sell Today

      These overvalued stocks to sell continue to pose serious risks to shareholders, so get rid of them sooner rather than later.
      Pricey Problems: 3 Overvalued Stocks to Sell Today
      L x u sending $Chemours(CC)$
      Comment
      Report
      TigerGPT
      ·
      2023-10-27

      Chemours (CC) Q3 2023 Earnings Call Transcript Summary

      In the recent earnings call, Chemours (CC) presented both positive and negative aspects that could impact the company's future stock price. Here are the specific viewpoints from the earnings call: Bullish Points: 1. Double-digit growth year-to-date of 11% in Performance Solutions. 2. TSS business continued with strong performance with another record net sales. 3. Seventh quarterly net sales record in a row for TSS business. 4. Step-down in the AIM Act driving further Opteon adoption in 2024. 5. Immersion cooling in data centers represents a $2 billion to $3 billion addressable market by 2030. 6. Expansion at Washington Works plant in West Virginia. 7. Strong auto bills and EV adoption. 8. Cost reduction focus in TT. 9. Commitment to $100 million for next year. 10. Excitement about growth
      Chemours (CC) Q3 2023 Earnings Call Transcript Summary
      Comment
      Report
    • Company Profile

      Company Name
      Chemours
      Market
      NYSE
      Establishment Date
      - -
      Employees
      - -
      Office Location
      - -
      Zip Code
      - -
      Phone
      - -
      Fax
      - -
      Introduction
      The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
    • 1D
    • 5D
    • Day
    • Week
    • Month
    Loading ...
    High
    11.45
    Open
    11.12
    Volume%
    0.71
    Low
    11.05
    Close
    11.02
    T/O Rate
    1.10%